ISKRA

Class [005]
Pharmaceutical Products

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment of psychoorganic syndrome, neuropsychiatrie and psychiatric diseases, nervous system disorders, Alzheimer disease, parkinson disease, vertigo of different origin, cardiovascular diseases, stroke, cerebrovascular stroke, vegetative-vascular dystonia, neurodegenerative diseases, neuroinfections, somatoform autonomic dysfunction, atherosclerosis, attention deficit disorder, diseases followed by abnormal changes in bioelectrical characteristics of the brain, congestive heart failure, hyperpiesis, neuroticism, psychosomatic disease, stress disorders, asthenic syndrome, neurotoxicosis and obesity; pharmaceutical and veterinary preparations for use in the prevention of parasitic infections, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, fungal infections, viral infections, parainfluenza, adenovirus, respiratory syncytial virus, coronavirus, labially herpes, genital herpes, chicken pox, herpes zoster, infectious mononucleosis, intestinal infections of viral etiology, including calicivirus, adenovirus, coronavirus, rotavirus, enteroviruses, enteroviral and meningococcal meningitis, hemorrhagic fever with renal syndrome, tick-borne encephalitis, bacterial infections, pseudotuberculosis, whooping cough, yersiniosis, pneumonia; pharmaceutical and veterinary preparations for use in the prevention of bacterial complications of viral infections, prevention of super bacterial infection; pharmaceutical preparations, namely, antihistamines; pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations, namely, psychotropics; pharmaceutical preparations for the treatment of erectile dysfunction, benign prostatic hyperplasia, prostatitis, dysuric disorders, autonomic disturbances of menopause; pharmaceutical preparations for improving digestion and reducing flatulence; pharmaceutical preparations for the treatment of irritable bowel syndrome, functional gastrointestinal disorders; pharmaceutical preparations, namely, anticonvulsants; pharmaceutical preparations, namely, antianxiety preparations; pharmaceutical preparations, namely, cough treatment preparations; pharmaceutical preparations, namely, preparations for the treatment of respiratory tract infection; pharmaceutical preparations for the treatment of rheumatic arthritis, osteoarthrosis, arthropathy, nonspecific ulcerative colitis; pharmaceutical antihypoxic preparations for use in the treatment of respiratory, pulmonary and circulatory diseases; pharmaceutical and veterinary preparations, namely, antioxidants; pharmaceutical nootropic preparations for use in the improvement of cognitive functions, for use in the treatment of memory diseases and disorders; pharmaceutical vasoprotective preparations for use in the treatment of blood disorders, hemorrhoids, varicose veins and vascular diseases; pharmaceutical antihyperglycemic preparations for use in the treatment of elevated levels of glucose in the blood and elevated levels of glycated hemoglobin in the blood; pharmaceutical preparations for the treatment of alcohol and nicotine addiction; homeopathic supplements; food for babies; dietary supplements for humans and animals; capsules sold empty for medicines; cachets for pharmaceutical purposes, namely, flat capsules sold empty for enclosing unpleasant-tasting pharmaceuticals; appetite suppressant pills